Key points are not available for this paper at this time.
A review of statins for primary prevention of cardiovascular disease could alter guidance for those with a 10 year risk of less than 10%. John Abramson and colleagues argue that statins have no overall health benefit in this population and that prescribing guidelines should not be broadened
Building similarity graph...
Analyzing shared references across papers
Loading...
Abramson et al. (Tue,) studied this question.
synapsesocial.com/papers/6a107381d478ddac0ffcf560 — DOI: https://doi.org/10.1136/bmj.f6123
John Abramson
Harvard University
H Rosenberg
Deutsche Nationalbibliothek
N. Jewell
London School of Hygiene & Tropical Medicine
BMJ
Harvard University
University of California, Berkeley
University of British Columbia
Building similarity graph...
Analyzing shared references across papers
Loading...